Median Diagnostics Inc. (XKON:233250)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,000
-2,000 (-14.29%)
At close: Apr 17, 2025, 3:30 PM KST
0.08%
Market Cap 24.43B
Revenue (ttm) 7.86B
Net Income (ttm) -567.58M
Shares Out 1.75M
EPS (ttm) -496.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9
Average Volume 19
Open 12,000
Previous Close 14,000
Day's Range 12,000 - 12,500
52-Week Range 8,600 - 18,500
Beta 0.16
RSI 44.14
Earnings Date n/a

About Median Diagnostics

Median Diagnostics Inc. develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals. Its products include ELISA for pigs, ruminants, avians, and horses; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; standard reagents, including AGID, HI, and FA; antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and an... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 233250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.